These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2497274

  • 1. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A, Eidelman A, Barak F, Alon H, Horn Y.
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of patients with superficial transitional cell carcinoma of the urinary bladder treated by intravesical mitomycin C.
    Pavlotsky A, Eidelman A, Barak F, Walach N, Horn Y.
    J Surg Oncol; 1995 Nov; 60(3):191-5. PubMed ID: 7475070
    [Abstract] [Full Text] [Related]

  • 3. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP, DeBruyne FM.
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [Abstract] [Full Text] [Related]

  • 4. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA, Van Helsdingen PJ, Kramer AE.
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [Abstract] [Full Text] [Related]

  • 5. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 6. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988 Apr; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 8. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO, Giuliano F.
    Ann Urol (Paris); 1988 Feb; 22(6):404-6. PubMed ID: 3146942
    [Abstract] [Full Text] [Related]

  • 9. Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancer.
    Maffezzini M, Simonato A, Lodolo C, Raber M, Carmignani G.
    Tumori; 1995 Feb; 81(3):191-3. PubMed ID: 7571026
    [Abstract] [Full Text] [Related]

  • 10. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH, Lee C.
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [Abstract] [Full Text] [Related]

  • 11. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
    Flüchter SH, Bichler KH, Harzmann R, Erdmann D.
    Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
    [Abstract] [Full Text] [Related]

  • 12. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC, Russo MA, deVere White RW.
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [Abstract] [Full Text] [Related]

  • 13. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 14. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC, Badalament RA, Lucas J, Drago JR.
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [Abstract] [Full Text] [Related]

  • 15. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Tolley DA, Hargreave TB, Smith PH, Williams JL, Grigor KM, Parmar MK, Freedman LS, Uscinska BM.
    Br Med J (Clin Res Ed); 1988 Jun 25; 296(6639):1759-61. PubMed ID: 3136828
    [Abstract] [Full Text] [Related]

  • 16. Severely contracted bladder following intravesical mitomycin C therapy.
    Wajsman Z, McGill W, Englander L, Huben RP, Pontes JE.
    J Urol; 1983 Aug 25; 130(2):340-1. PubMed ID: 6410085
    [Abstract] [Full Text] [Related]

  • 17. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J, Kühnel W, Dona S.
    Urologe A; 1989 Mar 25; 28(2):99-102. PubMed ID: 2655259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of intravesical mitomycin C in management of superficial bladder tumors.
    Bracken RB, Swanson DA, Johnson DE, De Furia D, von Eschenbach AC, Crooke S.
    Urology; 1980 Jul 25; 16(1):11-5. PubMed ID: 7395004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.